Isorientin4-O-glucoside 2'-O-p-hydroxybenzoagte for COVID-19

Isorientin4-O-glucoside 2'-O-p-hydroxybenzoagte has been reported as potentially beneficial for COVID-19 in the following study.

COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed isorientin4-O-glucoside 2'-O-p-hydroxybenzoagte in detail.